Team Publications
Year of publication 2019
Two distinct HIRA-dependent pathways handle H3.3 de novo deposition and recycling during transcription
biorxiv : DOI : 10.1101/2019.12.18.880716 Learn moreSummary
Fold upDesign on a Rational Basis of High-Affinity Peptides Inhibiting the Histone Chaperone ASF1
Cell Chemical Biology : 26(11):1573-1585 : DOI : DOI:https://doi.org/10.1016/j.chembiol.2019.09.002 Learn moreSummary
Fold upCombining epigenetic drugs with other therapies for solid tumours — past lessons and future promise
Nature Reviews Clinical Oncology : 17, 91–107 : DOI : 10.1038/s41571-019-0267-4 Learn moreSummary
Fold upDynamic Histone H3 Incorporation Fuels Metastatic Progression
Trends in Molecular Medicine : 25(11):933-935 : DOI : 10.1016/j.molmed.2019.09.003 Learn moreSummary
Fold upRegardless of the deposition pathway, aminoacid 31 in histone variant H3 is essential at gastrulation in Xenopus
biorxiv : DOI : 10.1101/612515 Learn moreSummary
Fold upDeciphering the mechanisms of chromatin states
Learn moreSummary
For the EU researcher magasine, Genevieve Almouzni talks about the work of the ChromADICT project in investigating the general principles that control chromatin states, work which could lead to a deeper understanding of many pathological cases : https://issuu.com/eu_research/docs/chromadict_eur19_h_res
Fold up
Year of publication 2018
Chromatin plasticity: A versatile landscape that underlies cell fate and identity.
Science : Vol. 361, Issue 6409:1332-1336 : DOI : DOI: 10.1126/science.aat8950 Learn morePOLE3-POLE4 Is a Histone H3-H4 Chaperone that Maintains Chromatin Integrity during DNA Replication
Molecular Cell : 72, 112–126 : DOI : DOI:https://doi.org/10.1016/j.molcel.2018.08.043 Learn moreSummary
POLE3-POLE4 Is a Histone H3-H4 Chaperone that Maintains Chromatin Integrity during DNA Replication
Fold upHistone supply: Multitiered regulation ensures chromatin dynamics throughout the cell cycle.
Journal of Cell Biology : DOI : DOI: 10.1083/jcb.201807179 Learn moreSummary
Histone supply: Multitiered regulation ensures chromatin dynamics throughout the cell cycle.
Fold upHigh-resolution visualization of H3 variants during replication reveals their controlled recycling
Nature Communications : 9:31-81. Learn moreSummary
High-resolution visualization of H3 variants during replication reveals their controlled recycling
Fold upFunctional activity of the H3.3 histone chaperone complex HIRA requires trimerization of the HIRA
Nature Communications : 9: 3103 : DOI : DOI: 10.1038/s41467-018-05581-y Learn moreSummary
Functional activity of the H3.3 histone chaperone complex HIRA requires trimerization of the HIRA subunit
Fold upGenome-wide Control of Heterochromatin Replication by the Telomere Capping Protein TRF2
Molecular cell : 70 : 449-461.e5 : DOI : 10.1016/j.molcel.2018.03.036 Learn moreSummary
Hard-to-replicate regions of chromosomes (e.g., pericentromeres, centromeres, and telomeres) impede replication fork progression, eventually leading, in the event of replication stress, to chromosome fragility, aging, and cancer. Our knowledge of the mechanisms controlling the stability of these regions is essentially limited to telomeres, where fragility is counteracted by the shelterin proteins. Here we show that the shelterin subunit TRF2 ensures progression of the replication fork through pericentromeric heterochromatin, but not centromeric chromatin. In a process involving its N-terminal basic domain, TRF2 binds to pericentromeric Satellite III sequences during S phase, allowing the recruitment of the G-quadruplex-resolving helicase RTEL1 to facilitate fork progression. We also show that TRF2 is required for the stability of other heterochromatic regions localized throughout the genome, paving the way for future research on heterochromatic replication and its relationship with aging and cancer.
Fold upYear of publication 2017
Targeting chromatin defects in selected solid tumors based on oncogene addiction, synthetic lethality and epigenetic antagonism.
Annals of oncology : official journal of the European Society for Medical Oncology : 254-269 : DOI : 10.1093/annonc/mdw552 Learn moreSummary
Although the role of epigenetic abnormalities has been studied for several years in cancer genesis and development, epigenetic-targeting drugs have historically failed to demonstrate efficacy in solid malignancies. However, successful targeting of chromatin remodeling deficiencies, histone writers and histone reader alterations has been achieved very recently using biomarker-driven and mechanism-based approaches. Epigenetic targeting is now one of the most active areas in drug development and could represent novel therapeutic opportunity for up to 25% of all solid tumors.
Fold upEssential role for centromeric factors following p53 loss and oncogenic transformation.
Genes & development : 463-480 : DOI : 10.1101/gad.290924.116 Learn moreSummary
In mammals, centromere definition involves the histone variant CENP-A (centromere protein A), deposited by its chaperone, HJURP (Holliday junction recognition protein). Alterations in this process impair chromosome segregation and genome stability, which are also compromised by p53 inactivation in cancer. Here we found that CENP-A and HJURP are transcriptionally up-regulated in p53-null human tumors. Using an established mouse embryonic fibroblast (MEF) model combining p53 inactivation with E1A or HRas-V12 oncogene expression, we reproduced a similar up-regulation of HJURP and CENP-A. We delineate functional CDE/CHR motifs within the Hjurp and Cenpa promoters and demonstrate their roles in p53-mediated repression. To assess the importance of HJURP up-regulation in transformed murine and human cells, we used a CRISPR/Cas9 approach. Remarkably, depletion of HJURP leads to distinct outcomes depending on their p53 status. Functional p53 elicits a cell cycle arrest response, whereas, in p53-null transformed cells, the absence of arrest enables the loss of HJURP to induce severe aneuploidy and, ultimately, apoptotic cell death. We thus tested the impact of HJURP depletion in pre-established allograft tumors in mice and revealed a major block of tumor progression in vivo. We discuss a model in which an “epigenetic addiction” to the HJURP chaperone represents an Achilles’ heel in p53-deficient transformed cells.
Fold upInsights into the molecular architecture and histone H3-H4 deposition mechanism of yeast Chromatin assembly factor 1.
eLife : DOI : 10.7554/eLife.23474 Learn moreSummary
How the very first step in nucleosome assembly, deposition of histone H3-H4 as tetramers or dimers on DNA, is accomplished remains largely unclear. Here, we report that yeast chromatin assembly factor 1 (CAF1), a conserved histone chaperone complex that deposits H3-H4 during DNA replication, binds a single H3-H4 heterodimer in solution. We identify a new DNA-binding domain in the large Cac1 subunit of CAF1, which is required for high-affinity DNA binding by the CAF1 three-subunit complex, and which is distinct from the previously described C-terminal winged-helix domain. CAF1 binds preferentially to DNA molecules longer than 40 bp, and two CAF1-H3-H4 complexes concertedly associate with DNA molecules of this size, resulting in deposition of H3-H4 tetramers. While DNA binding is not essential for H3-H4 tetrasome deposition in vitro, it is required for efficient DNA synthesis-coupled nucleosome assembly. Mutant histones with impaired H3-H4 tetramerization interactions fail to release from CAF1, indicating that DNA deposition of H3-H4 tetramers by CAF1 requires a hierarchical cooperation between DNA binding, H3-H4 deposition and histone tetramerization.
Fold up
